EASE (Estimation and Assessment of Substance Exposure) is a general model that may be used to predict workplace exposure to a wide range of substances hazardous to health. First developed in the early 1990s, it is now in its second Windows version. This paper provides a critical assessment of the utility and performance of the EASE model, and on the basis of this review, recommendations for the structure of a revised model are outlined. Twenty-seven stakeholders were interviewed about their previous use of EASE, perceived advantages and limitations of the model and suggestions for improvement. A subset of stakeholders was contacted on a second occasion to determine their views on the preferred outputs for an ideal exposure assessment model. Overall, stakeholders felt that the model should be updated to provide more accurate and precise exposure assessments. However, users also expressed the view that the simplicity and usability of the software model should not be compromised. Six studies investigating the validity of the inhalation exposure assessment section of EASE were identified. These showed that the model generally either predicted close to the measured exposures or overestimated exposure; though performance was highly variable. Two studies investigated the validity of the dermal exposure assessment and found that EASE produced considerable overestimates of actual dermal exposure (the amount of a substance that actually lands on the skin). A conceptual model of exposure was developed to investigate whether the structure of the EASE model is appropriate. Although EASE has a number of characteristics that describe exposure, it is a greatly simplified model and does not include all the important exposure determinants. More importantly, EASE can produce estimates of exposure that are ambiguous or incomplete. Our conceptual model may provide a rational basis for developing an improved version of EASE but further consultation is needed to decide the purpose and intended use of any successor to EASE.
INTRODUCTION
European Directives and Regulations require risk assessments for notified new and existing substances used in industry. These risk assessments, which must consider both the toxicity of the chemicals used and the likely levels of exposure, are designed to evaluate the potential for adverse health effects. The results of the risk assessment can have important economic consequences for industry and society so the process must produce a reliable and justifiable outcome.
When assessing the potential workplace exposures to new or existing substances, European regulators use a knowledge-based model called EASE (Estimation and Assessment of Substance Exposure), which was developed by the UK Health and Safety Executive (HSE). EASE is described in the Technical Guidance Documents in support of the European Union Directive and Regulation (European Commission, 1996) and an account of the development, and the underlying structure, has been provided by Cherrie et al. (2003) .
EASE was originally developed as a screening tool for regulatory risk assessments for new chemicals to be introduced into the European market. Its developers accepted that any uncertainties should lead to an overestimate of exposure rather than an underestimate. It was envisaged that if the estimated exposure was unacceptable then additional data would be collected to define exposure more reliably. However, since EASE was first introduced it has been used more widely for several different purposes for which it was not originally intended, e.g. retrospective exposure assessments and the prediction of exposure levels in specific workplaces.
Recent work to validate the predictions of EASE has highlighted weaknesses in the model when assessing inhalation exposure (Vincent et al., 1996; Devillers et al., 1997; ECETOC, 1997; Mark, 1999; Van Rooij and Jongeneelen, 1999; BredendiekKämper, 2001; Cherrie and Hughson, 2005) . Experience with EASE, both in actual risk assessments and in comparison with published exposure data, indicates a clear need for improvement in several respects. The numerical estimates of inhalation exposure often appear to be positively biased and this undermines the credibility of EASE in the eyes of the relevant stakeholders, particularly as the risk assessment may have important societal resource implications. Some work has also been undertaken to investigate the reliability of EASE predictions for dermal exposure (Cherrie et al., 2003) . This research found a similar tendency for positively biased exposure estimates from the model and other structural problems with the dermal exposure sections of EASE. HSE have already recognized the limitations for dermal exposure stating, 'the EASE model, particularly, is limited in this area' (Risk Assessment and Toxicology Steering Group, 1999) .
The presentstudy aimedto provide a systematic critical assessment of EASE's utility and performance, taking into particular account the experiences of stakeholders and findings of previous validation and consistency studies. On the basis of this review, recommendations for the structure of a revised exposure model are outlined, although further work is necessary to develop these plans into a fully functioning software package.
METHODOLOGY

Stakeholder interviews
It was originally anticipated that 30 stakeholder interviews would be conducted. To ensure that as close to the desired number of interviews were completed within the timescale of the project, contact details of over 200 people who had received a copy of EASE version 2 were obtained. This list was shortened and amended to a pool of approximately 45 key people who were known to the project team and felt to be suitably experienced and qualified to comment on the model and included those involved in regulatory risk assessment, practising occupational hygienists and academics. A semi-structured telephone interview was conducted to obtain information, including stakeholders understanding of the purpose of the EASE model, specific scenarios in which they had used EASE, their views on its limitations, accuracy and precision as well as suggestions for improvements. This was piloted before hand and no changes were deemed necessary. Those stakeholders from EU government agencies and industry were contacted on a second occasion to determine their views on the outputs desirable for an exposure assessment model to be used as a risk assessment tool.
Identification and review of EASE validation and consistency studies
Several members of the project team have been involved either with the development of EASE, and/or with its subsequent evaluation and therefore identified a number of previous studies to validate the model. In addition, stakeholders were specifically asked during the interviews if they were aware of any relevant research. A literature search was undertaken and papers that appeared relevant to this review were obtained. The authors were also aware of unpublished work and consistency studies by HSE and others. All of these published reports were made available for this review.
Evaluation of the structure of the EASE model
To determine the appropriateness of the structure of the EASE model, it was compared with a conceptual exposure model developed from one published by Schneider et al. (1999) . The model by Schneider et al. was originally developed for dermal exposure and was extended to include exposure by inhalation for the purpose of this review. The underlying structure of EASE was reviewed to ensure that it contains the key determinants of exposure as inputs to the model and that the exposure estimates vary with these determinants in expected ways.
RESULTS
Stakeholder interviews
Twenty-seven stakeholder interviews were completed (including the pilot interviews) during the lifespan of the project, with all except two being conducted by telephone. Contact could neither be made nor could interviews be arranged within the timescale of the project for the remaining stakeholders, with no individual declining to participate in the study. On average the interviews took 34 min (range 15-50 min). The remaining two stakeholders requested a paper copy of the questions, which were completed and returned. The participants were based in EU member states, Norway and the USA. Eight of the participants were government employees, 14 were chemical industry employees and five worked in academic institutions. A detailed account of the responses obtained in the stakeholders' interviews has been published (Cherrie et al., 2003) and a summary of the key findings is provided below.
Seven of the eight government stakeholders and approximately half of the industry and academic stakeholders were aware of the use of EASE in regulatory risk assessments. Overall, stakeholders viewed EASE as a tool used to assess exposures in the absence of actual measurements. Several academic and industrial stakeholders made reference to the use of the model by occupational hygienists to obtain exposure estimates for actual working environments. Views on the suitability of the model for this varied. Some participants felt that EASE can help prioritize activities of concern, highlighting whether further investigation is required, whilst others felt the model wasn't precise enough for particular workplace situations.
Although stakeholders were aware of the EASE model for several years, use of the model was variable. Three stakeholders (two industrial and one academic) had not actually used the software model although they had used its outputs and were aware of its structure. Seven people (mostly government stakeholders) reported using EASE extensively in their current work but the majority of respondents used the model intermittently depending on the work being undertaken.
As with all software tools, seamless installation and compatibility with the computer hardware are essential, as is a 'user friendly' interface and explanatory text. Only two stakeholders reported minor, nonspecific problems with the installation of the software. Overall, stakeholders found the computer interface simple and easy to operate although several stakeholders also felt that it was beginning to look dated.
Whilst many of the stakeholders found the explanatory text helpful and exposure categories clearly defined, 12 people expressed concerns. Particular problems were identified with the terms 'nondispersive' and 'wide-dispersive use' and the terminology 'inclusion onto matrix' gave rise to extensive discussion. While there is extensive explanatory text in the program, it was still felt that clarification of the terminology is needed, with some stakeholders suggesting that a collection of example exposure scenarios should be provided, so that use of the model can be clearly understood by all qualified users.
In addition to its original regulatory purpose, the EASE model has also been used for other applications outside the scope of its original domain. For example, two academic stakeholders had conducted validation studies, comparing the outputs of EASE with actual exposure measurements. Academic stakeholders had also used the model for retrospective exposure assessments in epidemiological studies and two industrial stakeholders also reported using the model for such assessments. Only the inhalation model was used in these instances, with stakeholders feeling that the outputs seemed realistic when compared to their own subjective assessments. EASE had also been used in several instances as a practical industrial hygiene tool, helping stakeholders prioritize situations where further action or actual measurements were needed.
Stakeholders' opinions regarding the accuracy and precision of EASE varied, depending on the purpose for which they had used the model and the substances assessed, although, overall, respondents felt that the model tended to overestimate exposure. The dermal model was reportedly rarely used. Stakeholders did not value or have confidence in this section of the model, stating that it was too simplistic and failed to include many important determinants of dermal exposure. They did recognize however that the lack of published information on quantitative dermal exposure and modelling has contributed to this.
Stakeholders' placed greater value on actual workplace measurements than computer predictions or models. Although use of the EASE model varied, general themes were observed. Stakeholders considered that a major strength of the EASE model was that substance assessment is placed in a clear framework where explicit assumptions are made. They also liked the fact that the model is easy to use; being a quick and easy decision-making tool based on actual workplace measurements with a tendency to overestimate exposure, thus erring on the side of caution.
Stakeholders also expressed concerns regarding the model and identified important limitations. They felt that any future development of the model should address these issues. Many believed that the model was too simplistic in that scenarios could not always be categorized correctly. For example, in the inhalation model only four options are available for the pattern of use of hazardous substances. This was considered insufficient given the wide variation of processes within and between workplaces.
Stakeholders stated that the exposure end points were too wide and often substantially overestimated exposure. The degree of overestimation was of particular concern and indeed inhibited some industrial users from continuing to use the model. Several limitations of the model were cited as possibly contributing to the wide ranges and overestimations. For instance, a major concern was that the underlying model data are historic, only from the UK and produced under circumstances specific to the needs of the HSE. Some felt the underlying exposure profiles might not be representative of the conditions now, and in the wider European context. EASE does not consider factors such as the proximity of the worker to the source, the quality of workplace controls or the impact of general ventilation rates. Stakeholders felt that there was no clear guidance on how to deal with mixtures. This was considered a serious limitation, given that most substances used at work are mixtures or used in a mixture with other substances. Overall, it was considered that significant improvements are needed to address these limitations to improve the robustness of the model and to improve specificity, accuracy and precision.
Some stakeholders suggested that the model be expanded in order to combine several tasks and allow a derived 8 h time-weighted average exposure level to be determined. This development of EASE would make the model more widely applicable. A further concern was the lack of information available on the development of the underlying architecture of EASE, leading to doubts about the quality and representativeness of the data, i.e. the problem of 'transparency'.
Several stakeholders regarded empirical models as secondary to sufficient actual measurements of exposure when assessing risk in specific workplaces. However, it was considered that the model should be sufficiently conservative, accurate and precise to support decision-making in the wider context of risk assessment. It was also emphasized that to achieve consistent and calibrated accuracy it would probably require a very sophisticated model underpinned by substantial data. The stakeholders were aware that compromises would have to be made on accuracy, precision and usability.
Stakeholders interviewed and reported to be employed by EU government agencies and industries were contacted again to participate in follow-up interviews. These interviews attempted to elicit the desired outputs for an exposure assessment tool for regulatory risk assessment. Nine individuals were approached to participate in these interviews and although none declined to participate, only six interviews could be arranged and undertaken within the timescale of the study. Five stakeholders stated that they preferred a range rather than a point estimate. They also would value other indicators of the exposure distribution so that the profile could be determined. Stakeholders were divided on the question of whether outputs should provide task-specific or 8 h time-weighted average predictions-arguments were made for and against both approaches. Opinion was also divided on whether estimates of uptake, i.e. the mass of hazardous substance entering the body, should be incorporated into an exposure model. Two stakeholders felt this increase in complexity was taking the model too far and what they really needed were transparent and reliable exposure values for further discussion. Other stakeholders considered that an assessment of uptake would be useful, emphasizing that clear guidance on what is meant by uptake would be required. Stakeholders were also asked to comment on dermal outputs. They were unanimous in agreeing that the model should output potential surface loading on the skin and that users should have the ability to select relevant anatomical areas for inclusion in the assessment. Three stakeholders felt that skin permeation and uptake parameters would be useful, though the remainder expressed reservations, stating that these were difficult issues and they were not sure how they should be dealt with. All stakeholders felt that the inclusion of the ingestion exposure route is unnecessary.
The question of whether a measure of systemic dose would be a useful feature for the revised EASE model was also posed. The general consensus was in favour but with reservations. The view was expressed that professional judgement rather than a model is needed.
Review of EASE validation and consistency studies
Inhalation exposure validity studies. Six reports describing studies of the validity of the inhalation exposure aspects of EASE were identified (Vincent et al., 1996; Devillers et al., 1997; ECETOC, 1997; Mark, 1999; Van Rooij and Jongeneelen, 1999; Bredendiek-Kämper, 2001; Cherrie and Hughson, 2005) . The early studies (Vincent et al., 1996; Devillers et al., 1997; ECETOC, 1997) were qualitative or provided limited information about the methods used to compare EASE predictions with measurements. The final three (Mark, 1999; Bredendiek-Kämper, 2001; Cherrie and Hughson, 2005) reported more rigorous quantitative evaluations, covering more than 160 EASE end points with more than 17 400 exposure measurements. Vincent et al. (1996) discussed the various limitations of EASE. They suggested that the documentation of the model was inadequate and the 'theoretical foundations' of the program are not well explained. They were also concerned that no allowance had been made for mixtures and felt that the 'pattern of use' categories were too general and vague to generate any precision in the estimation of exposure. These authors were also critical that the EASE model takes no account of personal protective equipment. Dervillers et al. (1997) and Vincent et al. (1996) described a series of 10 case studies, many of which were common to both papers, and so these were reviewed together. The case studies included scenarios such as paint stripping, manufacture of polyurethane foam and involved substances such as dichloromethane, chlorine and total inhalable dust. The EASE ranges were not corrected for the proportion of the hazardous substances in the mixture. In five of the scenarios the measured exposure levels were below the EASE predictions, in three cases the measurements and estimates were broadly in agreement and in the remaining two cases the measurements were higher than the EASE estimates. However, the data used in these studies were not fully described. In most cases the data represented 8 h average exposure, but in some cases shorter-term samples were used.
The European Chemical Industry Ecology and Toxicology Centre (ECETOC) evaluated EASE as part of a more general review of the European Union technical guidance document for risk assessment (ECETOC, 1997). Some specific criticisms were made, particularly of the definition of certain terms used, for example, 'dry manipulation'. They also suggested that EASE should address the issue of particle size more fully. The main criticism was that EASE does not consider the pattern or duration of the activity or process, which 'may provide strong overestimation if only a few short-term exposure conditions occur during daily work'.
Van Rooij and Jongeneelen (1999) describe the outcome of a one-day workshop on EASE in the Netherlands attended by 117 health and safety practitioners. During this, evaluations of 61 exposure scenarios were completed, 35 with gas or vapour exposures and 26 with dust exposures. The authors only had exposure ranges available and they judged the accuracy of the EASE predictions by taking the ratio of the geometric mean of the lower and upper measurements and the corresponding mean value of the lower and upper EASE range. None of the comparisons met the authors' criteria for underestimation and there was an overall tendency for the estimates to overestimate exposure. The average ratio of EASE estimates to measured exposures for gases and vapours was 3 and for dusts it was 3.7. Van Rooij and Jongeneelen (1999) suggested that EASE provided a way of 'distinguishing real risk situations from safe situations in a systematic and transparent way'. Mark (1999) , Bredendiek-Kämper (2001) and Cherrie and Hughson (2005) all attempted to provide a systematic evaluation of EASE across a wide range of conditions using existing measurement data.
The studies by Mark (1999) and Cherrie and Hughson (2005) summarized their results in different ways, but both quote the percentage of measurement data in the EASE range and whether the EASE estimates were generally in good agreement with the measurements. It was considered that if >50% of the measurements were within the appropriate EASE end-point range then the agreement between the model and the data was good, i.e. there was no bias. Cherrie and Hughson (2005) identified over 4000 inhalation exposure measurements covering 53 EASE end-points. For non-fibrous dusts the EASE model predictions were judged to be good in just over half of the end-point groups, although in the remainder, the estimates were too high. For the vapour comparisons, 6 of the 25 data sets were considered to be in good agreement with the predictions although the predictions were considered too high in 18 cases and too low in one. Mark (1999) also found that the exposures predicted from the EASE model overestimated the real measured exposures for both particulate and vapour pollutants and noted some difficulties in assigning the conditions reported in the workplace to categories within the decisions tree structure of EASE. Cherrie and Hughson (2005) included fibre measurements and for three of the end-points EASE was found to underpredict the measured exposure levels. However, this is partly an artefact of the EASE categories for fibres since for some situations EASE predicts zero exposure with no range. In most cases, the fibre exposures were low and if the EASE range was <0.1 fibres/ml, the agreement would have been good.
Bredendiek-Kämper (2001) compared EASE predictions for a number of workplace scenarios. Four of the six groups (various closed containment scenarios, rubber industry, plastics processing and textile industry) showed good agreement with the EASE predictions. For offset printing the EASE predictions were too low whilst for screen-printing they were too high. Bredendiek-Kämper summarized their data with interquartile ranges (25th-75th percentiles). For the purposes of this review, the data from an exposure scenario was said to agree with EASE if there was any overlap between the interquartile range for the measurements and the EASE end-point range. This is a less stringent criterion than that used by Mark (1999) and Cherrie and Hughson (2005) .
Dermal exposure validity studies. Two studies were identified that investigated the validity of the dermal exposure assessment section of EASE. Both of these concerned dermal exposure to dusts. The investigation described by Cherrie et al. (2003) involved an assessment of dermal zinc exposure carried out during galvanising work and zinc oxide production. A swab sampling method was used to sample dust on the hands of workers and the tasks carried out were categorized in terms of three different EASE endpoints. The measured daily exposures to the hands in the three scenarios were much lower than the predictions from EASE although as the EASE predictions increased so did the average measured exposure. Wheeler (personal communication) studied hand exposure for 27 subjects working in one tin and three lead factories. Again there was a clear indication that higher EASE categories were associated with higher measured exposures but the actual hand exposures to dust were almost two orders of magnitude lower than that predicted by EASE.
Both studies suggest that at least for dusts, EASE over predicts exposure to the hands, although there 139 Evaluation and further development of EASE model 2.0 was some suggestion that the model does capture some aspects of dermal exposure that are related to actual exposure. There were no validation data available to understand how well EASE performs with liquid chemicals or for non-metallic solids.
Consistency studies. Only one study was identified where the consistency of EASE users was investigated and the results of this are available as an appendix in Cherrie et al. (2003) . The study describes a comparison of exposure assessments from 15 workplace scenarios undertaken by 34 occupational hygienists. The assessments covered six non-fibrous dust scenarios, eight vapours and one fibrous dust scenario and for each there was a clear favoured outcome. For non-fibrous dusts the proportion of assessments in the most favoured end point ranged from 50% to just over 90% whereas for the vapour scenarios the proportion of assessments in the most favoured categories ranged from just under 30% to almost 90%. Data for the fibrous dust scenario is not fully described in the report. It was noted that there was better agreement between assessors for the dust scenarios and this was attributed to the greater number of possible outcomes (end points) for vapours compared with dusts (59 versus 12).
The main cause of differences between assessors arose for situations where a judgement had to be made, e.g. whether local extract ventilation appeared to be effective or ineffective. However, some differences were attributed to misunderstanding the terminology used within EASE. The authors do not discuss the possibility that the consistency of assessments will depend on the extent of information provided. For example, if the assessors were provided with a description of a scenario that unambiguously describes what should be input to EASE then almost all assessors would be expected to concur. A number of recommendations were made from this study. These include providing better guidance to the user about the procedures for using EASE, clearer help information on terms used in EASE and better training materials, including a number of worked examples.
Evaluation of the structure of the EASE model
Schneider and his co-workers (1999) developed a conceptual model for dermal exposure and in this review the model has been extended to include exposure by inhalation. The model is a source-receptor model, where the potential pathways from the source of the contaminant in the workplace are tracked through a number of compartments to the person who is exposed (Fig. 1) . This model forms the basis of the critique of EASE.
For dermal exposure the conceptual model identifies two environmental compartments (air and contaminated surfaces) plus two compartments associated with the person's clothing (inner and outer clothing layers). There are four key emission pathways from the source: to surfaces, to the air, to the outer clothing layer or direct emission to the skin and there are six further transfer processes linking model compartments. Exposure on the skin is described in terms of mass and concentration of contaminant in the skin contaminant layer, the area of skin contaminated and the duration of exposure. The conceptual model of inhalation exposure involves a similar series of environmental compartments, although because the air compartment is more important for inhalation this compartment must be elaborated by introducing a second subsidiary air volume around the person's head (i.e. their breathing zone). The two clothing layers have not been included because this review is less concerned with this level of detail. In addition, some of the potential dermal (and inhalation pathways) have been omitted for the sake of clarity. The simplified conceptual model was used to identify possible exposure determinants that should be included in a predictive exposure model. Clearly there are a number of important factors associated with the source and some of these are listed in Table 1 , along with some indication of their relationship with emission. In most cases the same factors are important in both the inhalation and dermal exposure model, although the impact on emission is not always in the same way.
Inhalation exposure is exclusively mediated through the air; therefore it is only the upper three compartments in the model, these being breathing zone air, room air and outside air, that are important (Fig. 1) . Cherrie (1999) and others have demonstrated that the size of the workroom and the quantity of air exchanged between the inside and outside of the building determine the average concentration of the hazardous substances in the workroom air. However, there will be a complex series of factors that determine the concentration and mass of contaminant exchanged between the room air and the breathing zone air. These include room shape, movement of people in the room and the physical work rate of the person. The impact of these factors cannot be easily predicted because they generally depend on the location of the worker in relation to the source(s) and the airflow patterns in the workroom. Computational fluid dynamics models can deal with this type of problem, but only for specific work situations. Inhalation exposure is conventionally defined, as the concentration in the breathing zone multiplied by the duration of exposure, although this is often expressed as a time-weighted average concentration averaged over either 8 h or 15 min. In addition, some researchers consider breathing rate to be an important factor in describing exposure for the purposes of assessing risk.
Transfer of hazardous substances onto the skin is potentially more complex. There are four compartments from which exposure might arise: direct from the source or contaminated surfaces, contaminated clothing and deposition of contaminants from air. Many factors influence these transfer routes, some of which are related to personal behaviour or are within the control of people at work, whilst the remainder concern the process and the possibility of increased emission from the source. The effects of most of these factors may in principle be generalized across different workplaces. Dermal exposure is often expressed as the mass of contaminant on the skin or the product of the mass per unit area and the area exposed. Cherrie and Robertson (1995) suggested that it would be more appropriate to consider the concentration of the hazardous substance in the skin contamination layer multiplied by the area of skin exposed and the duration of exposure. This exposure metric is more likely to be related to uptake through the skin than contaminant mass, although the mass is still important if the duration of exposure is sufficiently long, i.e. where the reservoir in the skin is insufficient to sustain uptake over the exposure period.
EASE was developed more than 10 years ago for a specific use, at a time when occupational exposure modelling and the realization of the importance of exposure determinants were only just emerging. We have provided a reflective critique based on current thinking and use of the model, which in some instances are outside its original domain as a screening tool.
EASE clearly recognizes the difference in exposure potential from dusts, liquids, vapours or gases and there is a different logic structure for each of the three physical states, which must be an important part of any exposure model. There is also a division between inhalation and dermal exposure in the model structure, which again must be a necessary prerequisite of any model because of the differences in exposure metrics and determinants for these different routes. However, the criteria for solids contributing to dermal exposure, i.e. that they are 'mobile' is obscure.
The particle size of solid dusts is incorporated into EASE, although again this is basically as a dichotomy: dusts that may become airborne (respirable/ inhalable) or those that cannot (granular). For aerosols, the other source terms from the conceptual model are process (dry crushing or grinding, dry manipulation or low dust techniques), presence of local ventilation and whether the particles readily aggregate. All of these factors have a fairly limited scope. There is a similar range of factors for liquids, although these are often grouped across different areas of the conceptual model. For example, 'pattern of use' includes some choices that relate to the control measures (e.g. closed system) and others that refer to the way people interact with the chemicals (e.g. nondispersive use). For liquids the system calculates the vapour pressure and uses this as part of the judgement of exposure, in line with the approach defined by the conceptual model. EASE does not include any real consideration of factors other than those related to the source. For inhalation exposure, for example, there is also no consideration of how workers might interact with the airborne pollutant or even how long they may be exposed to emissions from a process. The latter is a serious omission since exposure will vary pro rata with exposure duration. For dermal exposure the EASE decision logic is quite crude, relying mainly on the pattern of use (closed system, inclusion into matrix, non-dispersive use or wide-dispersive use) and the extent of contact (none, incidental, intermittent or extensive). The same criticisms apply to the pattern of use in the dermal exposure model as in the inhalation model. The extent of contact is only one of the identified transfer factors from the conceptual model.
We believe that the exposure determinants used in EASE are poorly defined and this must lead to inconsistent use of the model. For inhalation exposure the output is expressed in terms of concentration but it is unclear whether this is for a full 8 h work shift or only for the time while the activity or process operates. For dermal exposure the output from EASE is a mass of contaminant chemical per unit area of skin per day. However, these estimates only apply to the hands and forearms, although this is not immediately obvious from the model output.
EASE has a number of characteristics of the extended Schneider et al. (1999) conceptual model of exposure, particularly for the source terms for inhalation exposure. These terms appear to affect predicted exposure in a logical way. However, there are a number of concepts used in EASE that are not easily reconciled with the conceptual model, particularly pattern of use, and we are uncertain what, if any, impact this would have on predicted exposure. There are many factors that will affect exposure that are not included within the EASE model, such as room volume and general ventilation, although it is not clear from the conceptual model how important these are in arriving at an appropriate conclusion about exposure. The definitions of exposure, both for inhalation and the dermal route, are imprecise and this is likely to result in inconsistent application. The model provides insufficient information to fully characterize the exposure.
DISCUSSION
By consulting a variety of stakeholders and reviewing the available scientific literature, we have critically appraised the utility and performance of the EASE model to date. In essence, at the time EASE was developed, no other coherent predictive models or procedures were available which could predict exposure for a wide range of substances and circumstances and the legislative background and technical information available have shaped the continual development of EASE. For almost 10 years EASE has provided a basis for regulators to estimate 142 K. S. Creely et al.
occupational chemical exposure and there is no evidence that it has resulted in unsafe regulatory decisions. However, there is both documentary evidence and strong opinion amongst many stakeholders that the outputs from EASE are not sufficiently reliable for future needs. There is also increasing concern about the highly conservative nature of the EASE predictions and the potential impact of these on the competitiveness of European businesses. There are however many characteristics of EASE that are valued by stakeholders. These include linkage to actual workplace measurements, precautionary predictions, provision of predicted exposure ranges, with EASE being perceived as being easy and quick to use. At present, EASE provides exposure estimates for the inhalation and dermal exposure routes. These routes are important for regulators to consider while the inclusion of non-deliberate ingestion was not considered by stakeholders to be as important. However, we believe that for some types of substance, e.g. metals and biocides, inadvertent ingestion may be important and so we hope that it will be considered in any further development of EASE.
Stakeholders had diverse opinions about the choice of exposure metrics for the model output. For all routes of exposure the model should produce estimates of daily (8 h) exposure and separate exposure estimates for tasks that may be carried out within a working day. In this way the user can access the information they wish. We believe that in order to adequately assess inhalation exposure the model should produce estimates of the concentration of the chemical in the worker's breathing zone and the estimated average breathing rate so that uptake can be estimated if desired. It may also be useful to have predictions of the likely particle size distribution for aerosols, particularly where the aerosol is mostly inhalable or respirable. For dermal exposure, the main exposure parameters should be the mass of chemical on the skin surface, the concentration of the chemical in use and the area of skin exposed. For accidental ingestion the exposure metric should be the estimated mass of chemical taken into the mouth. The model should also explicitly contain information about the duration of the activity or activities that are being assessed, particularly if the aim is to produce a time-weighted average exposure estimate based on information about subsidiary tasks or activities.
However, the most important matter to address before any further development of EASE can be undertaken is to determine the key purpose of the model. EASE was originally developed for screening assessment of exposure for substances new to the European marketplace where it was envisaged that there would be very little information available about the uses of the product. Today EASE is used for purposes for which it was not originally intended or recommended, for example, to fill in gaps in exposure measurements in the regulatory risk assessment of existing substances, to provide data to support the setting of occupational exposure limits and to predict exposure levels in a specific workplace. It can be argued that the requirements for accuracy and precision differ for each of these possible uses. The four uses of models outlined usually differ in the quality of information available for the exposure assessment. In the case of new substances there may perhaps only be general information about the possible exposure scenarios. In the case of existing substances there should be better information available about the actual patterns of use and so it should be possible to obtain a more reliable estimate of exposure. In addition, there may also be exposure data available that could be used to augment or refine the model estimates. Finally, for a specific workplace prediction there could be detailed information available about the type and effectiveness of local ventilation systems, quantities of substance used, room temperatures and so on. All of this information could be used to support more detailed and accurate exposure modelling.
THE WAY FORWARD
The validation studies reviewed make a clear case for improved accuracy in the exposure estimates, particularly for gases and vapours. The question is whether it is possible to develop the present version of EASE to give the desired characteristics or whether a more radical solution is needed.
It would be possible to continue developing the existing version of EASE to address the limitations identified and to improve the accuracy of the predictions, for example, improving the calculation of vapour pressure. However these changes are likely to improve the reliability of the model predictions for only specific substances or scenarios and may not deliver the types of changes that stakeholder's desire. It has also been suggested that improved reliability could be achieved by carefully defining a subset of substances and uses for which EASE assessments are valid. This approach runs counter to the underlying philosophy of EASE: that it should be applicable to any and all substances and patterns of use. However, this type of strategy could be useful if EASE was to be restricted to a screening model for new substances, and it could usefully augment the evolutionary development of the model described above. Overall we have concluded that if we are to achieve the stakeholders' aspirations for EASE then we need to adopt a more revolutionary approach to the model, although clearly the actual approach will depend on clear agreement of the regulators and other stakeholders on the purpose of EASE. A range of alternative consumer and workplace exposure models are available, e.g. CONSEXPO (Consumer Exposure Model) developed by the Dutch National Institute of Public Health and the Environment) (van Veen, 2001 ) and MCCEM (Multi-Chamber Concentration and Exposure Model) developed by the US EPA Office of Pollution Prevention and Toxics (GEOMET Technologies, 1995) . All of these have a range of uses and various advantages and limitations; however, after careful consideration it is felt by the authors that neither of these provides a clear, better alternative to EASE. It is therefore felt that an alternative approach is required. Figure 2 shows the general scheme that we suggest for further development of EASE. It suggests both improved model software and the ability to combine this with available exposure data. We consider that a deterministic model is both appropriate for the further development of EASE and would most likely provide more accurate exposure estimates. This part of the model should be developed with the target of predicting the median exposure level in a single work situation to within a factor of three of the true value, which we consider is the best that can be achieved with current modelling approaches. The approach developed by Cherrie, Schneider and others for inhalation exposure (Cherrie et al., 1996; Cherrie and Schneider, 1999) can produce better agreement with measured exposures than EASE. This suggests that there is further scope to improve the reliability of exposure assessments for regulatory risk assessments. Much of the impetus for a deterministic model has come from the development of a clearer theoretical understanding of how people become exposed, as for example, in the conceptual model of dermal exposure developed by Schneider and colleagues . Using this approach is likely to be most appropriate.
The Bayesian Exposure Assessment Toolkit (BEAT) model is currently being developed to estimate dermal exposure (N. Warren, H. S. L. Sheffield, personal communication). It is based on the ideas of Phillips and Garrod (2001) and comprises a collection of software models built around a database containing more than 500 exposure measurements. Although it is still under development a copy was made available for this review. The user defines an exposure scenario and the program then compares this information with existing scenarios, selecting similar ones on a number of levels. The BEAT model has demonstrated that it is possible to develop an empirical model that can adapt to take account of new data. While we feel that this may be an appropriate way forward in a situation with a relatively limited range of scenarios it is unlikely to be sufficient on its own for the huge diversity of situations that may be encountered with general chemical use with only limited available measurement data. Nevertheless, BEAT has shown how the combination of model predictions and measurement data can provide a powerful framework for exposure assessment. We believe that this approach should be used in any further development of EASE. It will ensure that stakeholders are reassured that the exposure estimates arising from this process are linked to workplace measurements, with the added advantage that these links can be updated as new exposure measurements become available.
Currently exposure assessment is usually based upon either models or empirical data. We believe that combining both sets of information will maximize the possible accuracy and precision of any regulatory exposure assessment and would represent a major advance in its harmonisation. In our opinion the goal of exposure estimation should be to produce the most accurate and precise estimates of exposure possible. While a conservative assessment is clearly valued by stakeholders rather than having it implicit in the assessment we feel it is more appropriate to explicitly add in this conservatism afterwards through a 'safety factor' based upon the model variability and uncertainty. The ideal therefore, is a model that provides an accompanying measure of the uncertainty in the predicted exposures.
It is envisaged that eventually, exposure measurements will be held in a database along with appropriate contextual information. Relevant information in the database and the associated model predictions could be combined using a Bayesian statistical framework, similar to that in the BEAT model. A database is currently being developed for use within the European chemical industry known as the CEFIC Exposure Management System (CEMAS) (Cherrie, personal communication) . This will enable inhalation and dermal exposure measurements to be stored with a wide range of contextual information. We believe that this could provide the basis for the type of approach we have outlined here. Data could be collected routinely by industry or government, or could be specifically collected to address the needs of the regulatory risk assessment.
In many cases there may be data that is relevant to the particular scenario being evaluated, but not an exact match. For example, the substance to be assessed may be the same, but the formulation of the chemical product may be different, or the use pattern may be the same but the substance different. It would be desirable to use this data for updating the model predictions, but to do this we would need to have some criteria for judging when a scenario was 'similar' enough to another to allow this. We believe that there should be some further research to investigate the use of similarity algorithms for judging when data from one situation may be used to help predict exposure in another situation. This may be possible using our theoretical understanding of exposure, statistical analysis of existing data sets, along with the knowledge acquisition techniques that have been developed within the field of artificial intelligence.
To facilitate the combination of model predictions and data using Bayesian techniques we must first produce a model that predicts the variability and uncertainty in the exposure as well as the average exposure. This may easily be carried out using Monte Carlo simulation techniques. We envisage that rather than having predefined ranges, an updated version of EASE would present the user with a confidence interval for the mean predicted exposure.
We believe that further development of EASE must be seen as a priority for regulatory risk assessment of chemicals and that this initiative should be taken forward within the European context. Before a decision can be made on the best way to model and estimate exposure, model developers, regulators and industry need to discuss the purpose and intended use of a successor to EASE, as both of these will have a strong bearing on the form of the model. Acceptance of any new scheme is dependent on all relevant stakeholders being committed to the proposed approach.
